Göran Ando | MD
Göran has more than 35 years of leadership and management experience in the biotech and pharmaceutical industry, with Board positions at several global companies, including currently as Chairman [...]
Göran has more than 35 years of leadership and management experience in the biotech and pharmaceutical industry, with Board positions at several global companies, including currently as Chairman [...]
Andrew is an Operating Partner at Versant Ventures and has been the Chief Operating Officer at Ridgeline Discovery since 2018. Ridgeline is Versant’s Discovery Engine which creates and operates [...]
Joachim joined LSP in 2002 and is currently a Managing Partner and co-owner of the firm. His prime focus and responsibility within LSP is to invest in unlisted securities and the general [...]
Scott joined 5AM Ventures in 2003 as a Venture Partner and became a Managing Partner in 2004. He has over three decades of healthcare management experience with strategic leadership [...]
Marina joined Nouscom in 2016 as the Chief Operating Officer from Versant Ventures where she was an Operating Principal. Prior to Versant, Marina was at Novartis Pharma in Basel in various senior [...]
Sofia joined Andera Partners in 2009 and is currently a Partner in the Andera Life Sciences team. Prior to Andera Partners, Sofia was part of the Life Sciences team of L.E.K. Consulting London [...]
Thibaut joined Bpifrance in 2010 and is currently Senior Investment Director. He has more than 15 years of experience in Life Science investments. Thibaut started his career as a Scientist in a [...]
John has over 25 years of business development experience with some of the industry’s premier companies, including Genentech, Genzyme, Millennium Pharmaceuticals, MPM Capital, Biogen and [...]
Hakan Goker, PhD, is Managing Director of M Ventures and heads the Biotechnology investments covering Healthcare and Life Sciences. Hakan joined M Ventures in 2013 and has been investing in the [...]
Vincent has more than 25 years’ experience in the oncology and immunology field, including almost 15 years at GlaxoSmithKline (“GSK”) where he was Senior Vice-President and had responsibility for [...]
Nouscom is a private oncology company developing next generation immunotherapies, founded in 2015 by an experienced management team that has worked together for many years in previous successful enterprises. Nouscom’s proprietary technology platform harnesses the full power of the immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators.